Compare OGN & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | UMH |
|---|---|---|
| Founded | 1923 | 1968 |
| Country | United States | United States |
| Employees | N/A | 540 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | N/A |
| Metric | OGN | UMH |
|---|---|---|
| Price | $13.49 | $15.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $11.40 | ★ $17.75 |
| AVG Volume (30 Days) | ★ 2.4M | 530.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | 0.60% | ★ 5.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | $5.51 |
| Revenue Next Year | $1.67 | $2.51 |
| P/E Ratio | ★ $24.49 | $203.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $13.93 |
| 52 Week High | $13.49 | $17.44 |
| Indicator | OGN | UMH |
|---|---|---|
| Relative Strength Index (RSI) | 71.58 | 52.78 |
| Support Level | $10.05 | $14.76 |
| Resistance Level | N/A | $15.41 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 95.83 | 54.93 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.